Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Perfluorocarbons as blood substitutes.

K Waxman

    Annals of Emergency Medicine
    |December 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Perfluorocarbon (PFC) emulsions show potential for oxygen delivery, especially to tissues. However, their clinical benefit remains unclear due to side effects and limited half-life, necessitating further research.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Should critical care medicine be a formal part of the undergraduate curriculum?

    Journal of intensive care medicine·2014
    Same author

    Safety and efficacy of erythropoietin in traumatic brain injury patients: a pilot randomized trial.

    Critical care research and practice·2010
    Same author

    Intravenous interleukin-6 levels predict need for laparotomy in patients with bowel obstruction.

    The American surgeon·2002
    Same author

    Successful emergent thoracotomy for pericardial tamponade caused by late constrictive pericarditis after trauma.

    The Journal of trauma·2001
    Same author

    The effect of abrupt cessation of total parenteral nutrition on serum glucose: a randomized trial.

    The American surgeon·2000
    Same author

    Shock resuscitation: have critical transcutaneous values now been defined?

    Critical care medicine·2000

    Area of Science:

    • Biomedical Engineering
    • Pharmacology
    • Critical Care Medicine

    Background:

    • Perfluorocarbon (PFC) solutions face challenges in clinical use due to immiscibility with blood.
    • Emulsification is required for intravenous administration of PFCs as oxygen carriers.
    • Fluosol, an extensively studied PFC emulsion, has undergone clinical testing.

    Purpose of the Study:

    • To evaluate the efficacy and limitations of perfluorocarbon emulsions as oxygen-carrying agents.
    • To explore the potential applications of PFC solutions beyond anemia treatment.

    Main Methods:

    • Clinical testing of Fluosol, a perfluorocarbon emulsion.
    • Assessment of oxygen transport and delivery in vivo under high oxygen conditions.
    • Evaluation of tissue oxygen utilization from dissolved oxygen in PFCs.

    Related Experiment Videos

    Main Results:

    • Fluosol can transport oxygen in vivo, particularly at high inspired oxygen concentrations and arterial oxygen tensions.
    • PFC-dissolved oxygen is effectively delivered to and utilized by tissues.
    • In anemic patients, PFCs can contribute significantly to total oxygen consumption.

    Conclusions:

    • The clinical benefit of Fluosol remains unproven due to limited half-life, restricted infusion volumes, and unclear patient outcomes.
    • Adverse effects associated with Fluosol are likely linked to the emulsifying agent.
    • PFC solutions are experimental, with potential future applications in treating ischemic tissues rather than as anemia blood substitutes.